James Shell
Contributor since: 2010
Company: ISO-Help.com
Articles
Dissection Of American Capital Agency's And Annaly Capital Management's Q4 Earnings Announcements
AbbVie: Don't Fear The Humira Patent Expiration
AbbVie: Cash Out, Hold Or Reinvest?
The Abbott Labs/AbbVie Split Strategy: Cash Out, Hold, Reinvest?
The Real Opportunity In The Two Harbors/Silver Bay IPO
Update: The Current Value Of Phillips 66
The Upside Of Annaly's Forward Business Plan
Dissecting The Third Quarter American Capital Agency And Annaly Capital Management Earnings Releases
Analysis: The American Capital Agency And Annaly Capital Management Share Buybacks
Sandy's Potential Effects And Trading Opportunities For Oil Infrastructure
Coping With Mortgage REIT Chaos Part II: Additional Thoughts
Coping With Mortgage REIT Chaos
The West Coast Fuel Crisis: Origins, Opportunities, Lessons For The Future
Mortgage REITs And Risk Management
The Case For Resource Capital Corporation
Annaly Capital Management: The Safety Premium Of Preferred Stock
Revisionist Thinking On Dynex Capital
Analysis: Another Good Refinery Deal For Calumet
The Value Of Phillips 66
There's Still Upside In The Tesoro/BP Refinery Deal
The Future Price Of American Capital Agency
An Earnings Review Of The American Capital Agency And Annaly Capital Management
The Numbers On The Latest Armour Residential REIT Public Offering.
The Ethanol Disaster And The Ramifications For Producers
Update: CVR Partners And Corn Prices
The Future Price Of American Capital Agency
Invesco Mortgage Capital: Dump, Hold Or Reinvest?
Strategy Update: Armour Residential REIT And Chimera Investment Corporation
The Other Shoe Drops For Calumet
Don't Worry About Abbott Labs' Dividend
mREITs As A Proxy For Residential Real Estate
The Intriguing Story Of CVR Partners